#6 Clinical Trend: Hypertriglyceridemia
The Amarin Corporation PLC is developing a product, AMR101, that is an ultra-pure omega-3 fatty acid designed to treat hypertriglyceridemia. The company recently released an earnings report that included information about the upcoming product. Physicians are clearly interested in a new potential tool to treat this condition.
For more in-depth clinical information, see Hypertriglyceridemia.
Medscape © 2015
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Ryan Syrek. Top 10 Clinical Trends for June 2015 - Medscape - Jun 24, 2015.